company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62524000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62524000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35035000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35035000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27489000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6513000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1203000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7791000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15507000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11982000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,237000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,47000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,127000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-63000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11919000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4109000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7810000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7810000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7810000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38708000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38847000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39100000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q2,2013-04-01,2013-06-30,2014-08-13 16:17:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59318000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59318000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39038000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39038000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20280000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9545000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1462000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9041000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,6000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20054000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,226000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,195000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,255000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,109000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,335000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,494000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-159000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-159000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-159000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38709000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38709000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2013.0,Q3,2013-07-01,2013-09-30,2014-11-13 16:19:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45870000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45870000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33362000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33362000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12508000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6845000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1259000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6209000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,164000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14477000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1969000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,180000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-350000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-502000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2471000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-852000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1619000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1619000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1619000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38769000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38769000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40500000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q1,2014-01-01,2014-03-31,2015-05-14 06:00:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49003000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49003000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34007000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34007000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14996000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8638000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1352000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5994000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,184000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16168000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1172000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,476000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-260000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-704000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1876000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-696000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1180000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1180000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1180000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39767000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39767000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39300000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:00:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59711000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59711000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,47920000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,47920000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11791000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9556000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1454000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8585000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,13000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19608000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7817000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,504000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,94000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,243000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-167000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7984000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2605000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5379000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5379000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5379000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44644000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44644000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44800000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q3,2014-07-01,2014-09-30,2015-11-13 06:07:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,55877000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,55877000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43916000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43916000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11961000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9770000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1499000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8078000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-361000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18986000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7025000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-551000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,89000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,568000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1208000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5817000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3296000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2521000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2521000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2521000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41957000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41957000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42800000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56886000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56886000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43606000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43606000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13280000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12451000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1522000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6568000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20541000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7261000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,341000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,92000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1313000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1064000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6197000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5532000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-665000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-665000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-665000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44601000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44601000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66500000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 06:22:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53853000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53853000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40535000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40535000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13318000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11308000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1470000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10726000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,74000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23578000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10260000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,210000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,176000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,31000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10229000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3582000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6647000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6647000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6647000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44849000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44849000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44300000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 06:07:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,63868000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,63868000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46290000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46290000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17578000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9034000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1171000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11117000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21326000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3748000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,232000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-379000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-528000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4276000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1268000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3008000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3008000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3008000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45310000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45310000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43000000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 06:31:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,76912000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,76912000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43741000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43741000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33171000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8711000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1307000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8860000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-78000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18800000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14371000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,204000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,75000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3904000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4033000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10338000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2805000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7533000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7533000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7533000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44961000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44961000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46500000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59366000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59366000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,34464000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,34464000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24902000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10870000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1352000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8605000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20827000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4075000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,384000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,74000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,51000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-259000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3816000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1327000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2489000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2489000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2489000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45041000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46810000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41500000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 17:59:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,68033000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,68033000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36319000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36319000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31714000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9458000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1332000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10594000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21384000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10330000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,305000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,50000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-323000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-578000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9752000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2857000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6895000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6895000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6895000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44957000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45968000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46000000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:21:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,64223000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,64223000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36611000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36611000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27612000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10801000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1291000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9723000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21815000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5797000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,281000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,422000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,204000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6001000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2111000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3890000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3890000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3890000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45398000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47953000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43200000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 20:27:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,63543000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,63543000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,43575000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,43575000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19968000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10703000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1491000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12600000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24794000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4826000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,54000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-142000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-113000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4939000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1485000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3454000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3454000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3454000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45375000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47504000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44600000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56670000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56670000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33842000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33842000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22828000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11338000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1479000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11250000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-2643000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21424000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1404000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,191000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,91000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,200000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1504000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,611000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,893000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,893000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,893000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46069000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48057000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44700000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 19:13:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,65187000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,65187000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,38440000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,38440000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26747000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12234000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1596000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10732000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24562000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2185000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,237000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,87000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1138000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,988000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3173000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1201000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1972000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1972000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1972000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46025000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47866000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49300000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 18:40:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57916000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57916000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,37363000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,37363000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20553000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11665000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1756000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10075000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23496000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2943000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,264000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,124000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,969000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,829000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2114000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2213000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,99000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,99000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,99000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46101000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48215000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 19:38:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60402000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60402000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40021000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40021000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20381000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9221000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1629000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11446000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22296000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1915000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,134000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,123000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,612000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,601000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1314000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1997000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,683000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,683000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,683000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46107000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48367000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45600000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,58393000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,58393000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,41421000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,41421000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16972000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10998000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1721000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14030000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26749000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9777000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,124000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,782000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,888000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8889000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1748000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7141000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7141000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7141000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46514000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46514000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47600000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 19:34:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,71040000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,71040000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44976000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44976000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26064000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11669000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1876000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15460000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29005000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2941000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,100000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,106000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1265000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1259000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4200000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1347000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2853000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2853000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2853000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46557000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46557000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47600000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 19:11:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,75543000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,75543000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46283000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46283000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29260000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13407000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1963000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11340000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26710000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2550000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,124000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,43000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,24000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2574000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,958000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1616000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1616000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-773000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2389000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46241000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48281000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47800000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q3,2018-07-01,2018-09-30,2019-11-08 17:06:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89690000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89690000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,55001000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,55001000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34689000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13814000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2596000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16734000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33144000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1545000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,121000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1076000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-956000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,589000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1129000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1718000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1718000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-149000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1867000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46395000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46395000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47800000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,79790000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,79790000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,48887000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,48887000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30903000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16327000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3141000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14607000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34075000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3172000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,148000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-579000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-461000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3633000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1479000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2154000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2154000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3022000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,868000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46744000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50416000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43400000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:13:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,79047000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,79047000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46660000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46660000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32387000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12426000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2992000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15996000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31414000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,973000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,143000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,60001000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,60120000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61093000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14173000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46920000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46920000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-867000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,47787000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47107000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.01
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49894000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.96
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47300000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 19:11:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.01
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,80137000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,80137000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44885000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44885000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35252000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11021000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3221000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18606000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32848000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2404000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,450000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1250000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-822000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1582000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,598000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,984000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,984000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-326000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1310000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47239000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50075000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43700000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q3,2019-07-01,2019-09-30,2019-11-08 17:06:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,83383000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,83383000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,50002000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,50002000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33381000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10505000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3476000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19644000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33625000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-244000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,43000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,256000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1217000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1430000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1186000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,431000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,755000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,755000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1781000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1026000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46982000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49907000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47100000.0
Amphastar Pharmaceuticals Inc,AMPH,,0001297184,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
